Verrica Pharmaceuticals(VRCA) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition – Company reported $0 in product shipments in the third quarter of 2024 and recognized negative net product revenue of$1.9 million, including a provision for product returns of $1.7 million– – Company expects existing distributor inventory to support most demand for dispensed applicator units into the first quarter of 2025 – – Company continues to look for ways to manage expenses and expand ...